Heparin Alters Viral Serpin, Serp-1, Anti-Thrombolytic Activity to Anti-Thrombotic Activity
2008

Heparin Changes Serp-1's Activity from Anti-Thrombolytic to Anti-Thrombotic

publication Evidence: moderate

Author Information

Author(s): Li Xing, Schneider Heather, Peters Andrew, Macaulay Colin, King Elaine, Sun Yunming, Liu Liying, Dai Erbin, Davids Jennifer A., McFadden Grant, Lucas Alexandra

Primary Institution: Viron Therapeutics Inc.

Hypothesis

Heparin enhances the inhibitory activity of the viral serpin Serp-1 against thrombin.

Conclusion

Heparin facilitates Serp-1's ability to inhibit thrombin, which may help in managing thrombotic and inflammatory conditions.

Supporting Evidence

  • Heparin binds to Serp-1 and enhances its inhibition of thrombin.
  • Serp-1 can reverse thrombin-induced changes in cellular activation.
  • Heparin acts as a cofactor to facilitate Serp-1's anti-inflammatory functions.

Takeaway

Heparin helps a protein called Serp-1 work better to stop blood clots by making it easier for Serp-1 to catch a bad guy in the blood called thrombin.

Methodology

The study involved binding assays, chromogenic assays, and cellular membrane fluidity assays to evaluate the interaction between Serp-1 and thrombin in the presence of heparin.

Limitations

The study primarily focuses on in vitro experiments, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.2174/1874091X00802010006

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication